A randomized phase II trial of sipuleucel-T with concurrent or sequential abiraterone acetate (AA) plus prednisone (P) in metastatic castrate-resistant prostate cancer (mCRPC).
Eric Jay Small
Consultant or Advisory Role - Dendreon
Raymond S. Lance
No relevant relationships to disclose
Charles H. Redfern
No relevant relationships to disclose
Frederick E. Millard
Research Funding - Dendreon
Thomas A. Gardner
Honoraria - Dendreon
Lawrence Ivan Karsh
Consultant or Advisory Role - Dendreon
Honoraria - Dendreon
Research Funding - Urology Center of Colorado
Nancy Ann Dawson
Honoraria - Dendreon
Research Funding - Dendreon
Candice McCoy
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Andrew Stubbs
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Todd DeVries
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Corazon P. dela Rosa
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Nadeem A. Sheikh
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Neal D. Shore
Consultant or Advisory Role - Amgen; Astellas Pharma; Bayer; Dendreon; Janssen; Medivation; Millennium